VanishID | $10,000,000 | (Apr 24, 2025)
Coologics | $3,000,000 | (Apr 24, 2025)
Cloud Retail | $3,000,000 | (Apr 24, 2025)
Certified by Founder
Lodge
Bicara Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/03/2023
- Series B
- $108,000,000
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.
- Industry Biotechnology Research
- Website https://www.bicara.com/
- LinkedIn https://www.linkedin.com/company/bicara-therapeutics/
Instrumentl | $55,000,000 | (Apr 24, 2025)
Scamnetic | $13,000,000 | (Apr 24, 2025)
Neurolabs | $7,800,000 | (Apr 24, 2025)
Bloom Credit | $10,500,000 | (Apr 24, 2025)
HelloSky | $5,500,000 | (Apr 24, 2025)
Synthetic Design Lab | $20,000,000 | (Apr 24, 2025)
Hokodo | $11,355,829 | (Apr 24, 2025)
Nourish | $70,000,000 | (Apr 24, 2025)
Alpaca | $52,000,000 | (Apr 24, 2025)